Workflow
Digital Health
icon
Search documents
XR Immersive Technologies Provides Corporate Update Following Completion of Financial Filings
Thenewswire· 2025-12-03 05:05
 Vancouver, BC – TheNewswire - December 2, 2025 – XR Immersive Technologies Inc. (CSE: VRAI, OTC: FNTTF, FSE: 79W0) (“XR” or the “Company”) is providing a corporate update following the appointment of Shafin Diamond Tejani as Special Advisor, originally announced on October 9, 2025.Since the appointment, the Company has focused on three core priorities: (1) completing all outstanding financial filings, (2) advancing commercialization of its health-related digital twin technology, and (3) progressing through ...
DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio
Globenewswire· 2025-12-02 13:01
DNA-based Colorectal Cancer Screening as a Home TestBERKELEY, Calif. and MAINZ, Germany, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company“), molecular genetics diagnostic company specializing in the early detection of cancer, today announced that its test ColoAlert® has been added to the portfolio of DoctorBox, one of Germany’s leading pioneers in digital health. This marks another important milestone in Mainz Biomed’s European growth strategy and highlights ...
DarioHealth Far Exceeds 2025 New Client Target with 79 New Accounts Signed Year-to-Date
Prnewswire· 2025-12-02 13:00
Accessibility StatementSkip Navigation Data-driven outcomes drive employer adoption, highlighting Dario's market leadership as partner of choice, underscoring employer confidence, repeatability and scalability NEW YORK, Dec. 2, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today announced that it has secured 34 new employer clients in the past two weeks, reaching a total of 79 clients signed year-to-date, exceeding its 202 ...
Rocket Doctor AI Announces Strong Q3 Momentum Driven by U.S. Expansion, New Payer Contracts and Platform Growth
Globenewswire· 2025-12-02 13:00
Continued organic quarter over quarter revenue growth despite expected summer seasonalityEarnings per share for Q3, 2025: ($0.05) per share.Oversubscribed raise of C$4.23m contributing to significantly improved cash position.Announced signed in-network contracts and credentialing with several major U.S. insurance companies. Extending Rocket Doctor’s U.S. total in-network reach to over 13 million members. Vancouver, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (formerly Treatment ...
Victory Square Technologies Reports Q3 2025 Financial Results & Provides Corporate Update
Newsfile· 2025-12-02 03:28
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Victory Square Technologies Inc. (CSE: VST) (FSE: 6F6) (OTC Pink: VSQTF) ("Victory Square" or the "Company") today released its financial results for the three and nine months ended September 30, 2025, and provided a comprehensive update on key developments across its digital health, biotech, pet wellness, climate tech, and immersive technology platforms.The Company's complete financial statements and Management Discussion & Analysis ("MD&A ...
CIMG Inc.'s Tokenized Stock to Launch Publicly on FlowStocks
Prnewswire· 2025-11-28 16:33
Accessibility StatementSkip Navigation  BEIJING, Nov. 28, 2025 /PRNewswire/ -- CIMG Inc. ("CIMG" or the "Company") (Nasdaq: IMG), a business group specializing in digital health and sales development, which utilizes technology and marketing to enhance its business partners' sales growth and commercial value, today announced that its tokenized stock, which it previously announced was authorized for issuance on the FlowStocks platform, has completed testing and has be officially launched for public trading ...
Rocket Doctor Inc. Selected to Speak at Google Accelerator Alumni Event and Present at Demo Day for Heal.LA Accelerator
Globenewswire· 2025-11-26 13:00
Core Insights - Rocket Doctor AI Inc. participated in the Google Accelerator Alumni Summit, where CEO Dr. Bill Cherniak shared insights on the company's journey and the deployment of AI in healthcare [1][2][7] - The company is leveraging Google's Gemini models for its AI Nurse platform and is exploring new opportunities following the launch of Gemini 3.0 [3][7] - Rocket Doctor AI aims to enhance access to healthcare through its digital health platform, which supports physician autonomy and patient care coordination [4][10] Company Developments - Dr. Cherniak's participation in the summit included discussions with senior leaders from Google DeepMind and engineering teams, focusing on product planning and next-generation capabilities [2][5] - The company has graduated from the Heal.LA Accelerator program, showcasing innovative approaches to increase healthcare access for millions [4][7] - Rocket Doctor AI's technology has empowered over 300 MDs to manage more than 700,000 patient visits, improving efficiency and expanding patient access [9][10] Future Outlook - The launch of Gemini 3.0 is seen as a pivotal moment for accelerating clinical innovation within Rocket Doctor AI [6] - The company is committed to developing patient-centered, clinically sound AI solutions, with plans to strengthen access to care as part of its innovation roadmap into 2026 [6][10] - Rocket Doctor AI's proprietary Global Library of Medicine (GLM) is a key component of its technology, developed with input from numerous physicians worldwide [8][10]
Hims & Hers Expands Care Scope as Digital Health Platforms Evolve
ZACKS· 2025-11-25 18:31
Core Insights - Hims & Hers Health, Inc. (HIMS) operates a digital health platform providing access to clinical care and wellness services, focusing on sexual health, dermatology, hair loss, mental health, and weight loss [2][3] - The company has expanded its clinical offerings, including low testosterone care and menopause treatments, and plans to introduce comprehensive lab-testing services and a longevity-focused specialty [3][7] - HIMS is also pursuing international growth through the acquisition of ZAVA in Europe and plans to enter the Canadian market in 2026 [3][7] Financial Performance - Hims & Hers shares have increased by 56.3% year to date, significantly outperforming the industry growth of 10.1% [6] - The forward 12-month price-to-sales (P/S) ratio for HIMS is 3.2X, lower than the industry average of 5X but higher than its three-year median of 2.6X [9] - The Zacks Consensus Estimate for HIMS' earnings per share (EPS) in 2025 indicates a 77.8% improvement from 2024 [9][10] Earnings Estimates - The current quarter EPS estimate is 0.04, with a next quarter estimate of 0.14, and a current year estimate of 0.48, projecting a year-over-year growth of 77.78% [10] - The next year EPS estimate is 0.60, reflecting a growth of 24.49% [10]
Hinge Health Reduces MRIs and X-Rays for Back Pain by 60%
Businesswire· 2025-11-24 16:00
SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced a new study showing that participants in its chronic back pain program had substantially fewer imaging visits, such as X-rays and MRIs, compared to a similar group of individuals who sought traditional PT care. The peer-reviewed study, published in The Journal of Health Economics and Outcomes Research found that of the 4,330 participants, those who used Hinge Health had 60% fewer imaging visits for low back pain at. ...
Medical Care Technologies Inc. (OTC Pink:MDCE) Ranked #2 on InvestorsHub's Breakout Board as Subsidiaries Surpass $848,000 in Revenue and AI Technology Development Advances
Accessnewswire· 2025-11-24 14:30
"Subsidiaries deliver strong revenue performance as MDCE advances development of innovative AI-driven health and nutrition technologies." MESA, ARIZONA / ACCESS Newswire / November 24, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE), is a diversified holding company focused on technology, digital health innovation, and premium collectibles, announces that it was ranked #2 on InvestorsHub's Breakout Board on Friday, November 21, 2025-reflecting increased investor attention and continued operational tra ...